70771-1353 : Zaldyon 800 mg Oral Tablet, Delayed Release


NDC70771-1353
Labeler: Cadila Healthcare Limited
Product Type: Human Prescription Drug
Drug Name:  Zaldyon
Dosage Form: Oral Tablet, Delayed Release
Application #: ANDA203286
Rev. Date: 


Appearance:


Markings: 435
Shapes:  Capsule
Colors:  Red
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 70771-1353-4: 10 BLISTER PACK IN 1 CARTON (70771‑1353‑4) > 10 TABLET, DELAYED RELEASE IN 1 BLISTER PACK (70771‑1353‑2)
  • 70771-1353-8: 180 TABLET, DELAYED RELEASE IN 1 BOTTLE (70771‑1353‑8)

Active Ingredients:

  • Mesalamine

Dosage Strength:

  • 800 mg

Inactive Ingredients:

  • Acetyltributyl Citrate
  • Silicon Dioxide
  • Ferric Oxide Red
  • Magnesium Stearate
  • Methacrylic Acid
  • Cellulose, Microcrystalline
  • Povidone
  • Sodium Starch Glycolate Type a Potato
  • Talc
  • Titanium Dioxide
  • Ferrosoferric Oxide
  • Isopropyl Alcohol
  • Butyl Alcohol
  • Propylene Glycol
  • Ammonia
  • Shellac /

Pharmaceutical Classes:

  • Aminosalicylate [EPC]
  • Aminosalicylic Acids [CS]

Related Products:

Based on records with the same trade name.
  • 70710-1543 Zaldyon 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70771-1353 QR Code

< Prev: 70771-1352Next: 70771-1355 >

Related Discussions:

Will PENTASA (mesalamine) contradict diabetes medications
I am taking PENTASA (mesalamine) 500 mg tablets daily (6 tabs daily) and I also use azoran 5 mg two tabs daily. Will it ...
Cheap Purchase of Mesalamine Enemas
I am interested in self-employment. I have Ulcerative Colitis. I need this medication to stay alive. My doctor tells me ... 1 reply
Asacol (mesalamine) delayed-release tablet
mesalamine delayed-release tablet information...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.